These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17389319)

  • 1. Efficacy of propafenone in paramyotonia congenita.
    Alfonsi E; Merlo IM; Tonini M; Ravaglia S; Brugnoni R; Gozzini A; Moglia A
    Neurology; 2007 Mar; 68(13):1080-1. PubMed ID: 17389319
    [No Abstract]   [Full Text] [Related]  

  • 2. A new case of autosomal dominant myotonia associated with the V1589M missense mutation in the muscle sodium channel gene and its phenotypic classification.
    Ferriby D; Stojkovic T; Sternberg D; Hurtevent JF; Hurtevent JP; Vermersch P
    Neuromuscul Disord; 2006 May; 16(5):321-4. PubMed ID: 16624558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced muscle-fiber conduction but normal slowing after cold exposure in paramyotonia congenita.
    Blijham PJ; Drost G; Stegeman DF; Zwarts MJ
    Muscle Nerve; 2008 Jan; 37(1):23-6. PubMed ID: 17823953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of paramyotonia congenita without periodic paralysis: electrophysiological and molecular genetic studies.
    Park JH; Lee YW; Park SA; Lee TK; Rho HJ; Sung KB
    Neurologist; 2010 May; 16(3):203-5. PubMed ID: 20445432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient with episodic ataxia and paramyotonia congenita due to mutations in KCNA1 and SCN4A.
    Rajakulendran S; Tan SV; Matthews E; Tomlinson SE; Labrum R; Sud R; Kullmann DM; Schorge S; Hanna MG
    Neurology; 2009 Sep; 73(12):993-5. PubMed ID: 19770477
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe phenotypes of paralysis periodica paramyotonia are associated with the Met1592Val mutation in the voltage-gated sodium channel gene (SCN4A) in a Chinese family.
    Feng Y; Ji X; Sun X; Wang H; Zhang C
    J Clin Neurosci; 2011 Aug; 18(8):1138-40. PubMed ID: 21665479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow inactivation: slow but not dull.
    Ruff RL
    Neurology; 2008 Mar; 70(10):746-7. PubMed ID: 18316687
    [No Abstract]   [Full Text] [Related]  

  • 8. Human skeletal muscle sodium channelopathies.
    Vicart S; Sternberg D; Fontaine B; Meola G
    Neurol Sci; 2005 Oct; 26(4):194-202. PubMed ID: 16193245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New mutation of the Na channel in the severe form of potassium-aggravated myotonia.
    Kubota T; Kinoshita M; Sasaki R; Aoike F; Takahashi MP; Sakoda S; Hirose K
    Muscle Nerve; 2009 May; 39(5):666-73. PubMed ID: 19347921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of repetitive nerve stimulation, exercise, and cold in differentiating myotonic disorders.
    Michel P; Sternberg D; Jeannet PY; Dunand M; Thonney F; Kress W; Fontaine B; Fournier E; Kuntzer T
    Muscle Nerve; 2007 Nov; 36(5):643-50. PubMed ID: 17654559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paramyotonia congenita due to a de novo mutation: a case report.
    Fukudome T; Izumoto H; Goto H; Matsuo H; Yoshimura T; Sakoda S; Shibuya N
    Muscle Nerve; 2003 Aug; 28(2):232-5. PubMed ID: 12872329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V.
    Mohammadi B; Mitrovic N; Lehmann-Horn F; Dengler R; Bufler J
    J Physiol; 2003 Mar; 547(Pt 3):691-8. PubMed ID: 12562902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy in myotonic disorders and in muscle channelopathies.
    Meola G; Sansone V
    Neurol Sci; 2000; 21(5 Suppl):S953-61. PubMed ID: 11382195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant sodium channels, myotonia, and propofol.
    England JD
    Muscle Nerve; 2001 Jun; 24(6):713-5. PubMed ID: 11360254
    [No Abstract]   [Full Text] [Related]  

  • 15. Paramyotonia congenita and skeletal sodium channelopathy.
    Tamaoka A
    Intern Med; 2003 Sep; 42(9):769-70. PubMed ID: 14518660
    [No Abstract]   [Full Text] [Related]  

  • 16. Thr1313Met mutation in skeletal muscle sodium channels in a Japanese family with paramyotonia congenita.
    Kinoshita M; Sasaki R; Nagano T; Matsuda A; Nakamura S; Takahama M; Ohnuki M; Hasegawa H; Mitarai T; Hirose K
    Intern Med; 2003 Sep; 42(9):856-61. PubMed ID: 14518676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paramyotonia congenita with an SCN4A mutation affecting cardiac repolarization.
    Péréon Y; Lande G; Demolombe S; Nguyen The Tich S; Sternberg D; Le Marec H; David A
    Neurology; 2003 Jan; 60(2):340-2. PubMed ID: 12552059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.
    Desaphy JF; De Luca A; Tortorella P; De Vito D; George AL; Conte Camerino D
    Neurology; 2001 Nov; 57(10):1849-57. PubMed ID: 11723275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anesthetic propofol modulates gating in paramyotonia congenita mutant muscle sodium channels.
    Haeseler G; Störmer M; Mohammadi B; Bufler J; Dengler R; Piepenbrock S; Leuwer M
    Muscle Nerve; 2001 Jun; 24(6):736-43. PubMed ID: 11360256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
    De Luca A; Pierno S; Liantonio A; Desaphy JF; Natuzzi F; Didonna MP; Ferrannini E; Jockusch H; Franchini C; Lentini G; Corbo F; Tortorella V; Camerino DC
    Neuromuscul Disord; 2004 Jul; 14(7):405-16. PubMed ID: 15210163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.